ClinicalTrials.Veeva

Menu

Ammonia Metabolism Assessed by Ammonia Infusion (NH4 inf)

A

Aarhus University Hospital

Status

Unknown

Conditions

Liver Failure, Chronic
Ammonia; Metabolic Disorder

Treatments

Other: Ammonia infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT04585672
1-16-02-297-20

Details and patient eligibility

About

The present study will develop a method to assess ammonia metabolism by ammonia infusion and investigate ammonia production and clearance in healthy individuals and in patients with liver cirrhosis.

Enrollment

20 estimated patients

Sex

Male

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria - Healthy controls:

  • Alcohol < 40g/day
  • BMI < 30
  • Diseased or medicated

Inclusion Criteria - Patients with cirrhosis:

  • Child-Pugh A or B cirrhosis
  • BMI < 30

Exclusion Criteria:

  • Child-Pugh score C
  • Kidney failure (eGFR < 60 mL/min/1.73m2)
  • Overt hepatic encephalopathy or more than one previous 1 episode of overt hepatic encephalopathy
  • Acute bacterial infection
  • Cancer
  • Diabetes
  • Ammonia-targeted treatment of hepatic encephalopathy other than lactulose (including Rifaximin and branched-chain amino acids)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Healthy and Cirrhosis
Other group
Description:
Ammonia infusion with and without ammonia targeting
Treatment:
Other: Ammonia infusion

Trial contacts and locations

1

Loading...

Central trial contact

Peter Lykke Eriksen, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems